Canadians' annual Rx spend = $578Study indicates three out of four Canadians filling at least one prescription annually Canada leads in hypertension treatmentU of Calgary study shows drop in deaths Olmetec: new angiotensin II blocker coming soon Schering-Plough will soon be launching Olmetec and Olmetec Plus for the treatment of mild to moderate hypertension. New hypertension guidelines target diabetes and unsafe drug combo DOCTOR TO DOCTOR: Atrial fibrillation explained (again) A self-guided plan for reducing high blood pressure Pfizer to acquire Wyeth for $68 billion Pfizer Inc., the world's leading drug maker, is buying Wyeth for $68 billion US. Elderly exhibit seasonal trends in blood pressure Higher blood pressures seen in winter, prompting researchers to suggest closer monitoring of patients in cold weather NEPHROLOGY: Overnight hemodialysis improves survival rates CARDIOLOGY: Rising C-section rate a concern in women with congenital heart disease Longer hospital stays, increased risk of cardiac complications noted First Previous 91 92 93 94 95 Next Last
